Direct comparison of the effects of nitroprusside, SIN 1, and various nitrates on platelet aggregation and soluble guanylate cyclase activity
- PMID: 2904706
- DOI: 10.1016/0049-3848(88)90036-9
Direct comparison of the effects of nitroprusside, SIN 1, and various nitrates on platelet aggregation and soluble guanylate cyclase activity
Abstract
We have directly compared the effects of the nitrates isosorbide-5-mononitrate, nitroglycerin and isosorbide dinitrate and of the nitric oxide-containing sodium nitroprusside and 3-morpholino-sydnonimine (SIN 1) as well as of the bioinactive precursor of SIN 1, molsidomine, on platelet activating factor-induced platelet aggregation and activation of soluble guanylate cyclase. The effects of these agents on the aggregation and on soluble guanylate cyclase activity of human platelets were closely correlated. Whereas nitroprusside and SIN 1 were very potent inhibitors of aggregation and activators of soluble guanylate cyclase in micromolar concentrations, the other drugs were effective only at millimolar concentrations. Preincubation of platelets with cysteine did not or only slightly increase the ability of isosorbide-5'-mononitrate and isosorbide dinitrate to inhibit aggregation, but a clear increase was observed after preincubation with nitroglycerin. These data support the concept that cyclic GMP is the mediator of nitric oxide-induced inhibition of platelet aggregation and indicate that nitrates cannot directly inhibit aggregation or be converted to nitric oxide-containing agents by a specific mechanism in platelets. The data also suggest that SIN 1 and nitroprusside, but not or only to a certain degree the nitrates, can be considered as exogenous endothelium-derived relaxing factors.
Similar articles
-
Inhibition of platelet activating factor-induced platelet aggregation by molsidomine, SIN-1, and nitrates in vitro and ex vivo.J Cardiovasc Pharmacol. 1989;14 Suppl 11:S115-9. J Cardiovasc Pharmacol. 1989. PMID: 2484688
-
[Comparison of the effects of SIN-1, sodium nitroprusside and nitrate derivatives on the inhibition of blood platelet aggregation and activation of soluble platelet guanylate-cyclase].Pathol Biol (Paris). 1987 Feb;35(2 Pt 2):251-4. Pathol Biol (Paris). 1987. PMID: 2882462 French.
-
[Inhibition of platelet aggregation by endothelium-derived relaxing factor-like agents].Med Klin (Munich). 1990 Feb;85 Suppl 1:18-22. Med Klin (Munich). 1990. PMID: 2185403 Review. German.
-
Synergistic interaction of adenylate cyclase activators and nitric oxide donor SIN-1 on platelet cyclic AMP.Eur J Pharmacol. 1995 May 26;289(3):455-61. doi: 10.1016/0922-4106(95)90154-x. Eur J Pharmacol. 1995. PMID: 7556414
-
[Soluble guanylate cyclase in the molecular mechanism underlying the therapeutic action of drugs].Biomed Khim. 2012 Jan-Feb;58(1):32-42. doi: 10.18097/pbmc20125801032. Biomed Khim. 2012. PMID: 22642150 Review. Russian.
Cited by
-
Organic nitrates and nitrate resistance in diabetes: the role of vascular dysfunction and oxidative stress with emphasis on antioxidant properties of pentaerithrityl tetranitrate.Exp Diabetes Res. 2010;2010:213176. doi: 10.1155/2010/213176. Epub 2010 Dec 27. Exp Diabetes Res. 2010. PMID: 21234399 Free PMC article. Review.
-
Modulation of the pharmacological actions of nitrovasodilators by methylene blue and pyocyanin.Br J Pharmacol. 1992 Aug;106(4):838-45. doi: 10.1111/j.1476-5381.1992.tb14422.x. Br J Pharmacol. 1992. PMID: 1327388 Free PMC article.
-
The effect of nitric oxide-donating vasodilators on monocyte chemotaxis and intracellular cGMP concentrations in vitro.Eur J Clin Pharmacol. 1993;45(1):53-8. doi: 10.1007/BF00315350. Eur J Clin Pharmacol. 1993. PMID: 8405030
-
Effect of molsidomine on ex vivo platelet aggregation and plasma guanosine 3':5'-cyclic monophosphate levels in healthy volunteers.Klin Wochenschr. 1990 Feb 15;68(4):213-7. doi: 10.1007/BF01662718. Klin Wochenschr. 1990. PMID: 2156106
-
Effects of an oral dose of isosorbide dinitrate on platelet function and fibrinolysis in healthy volunteers.Br J Clin Pharmacol. 1993 Feb;35(2):143-51. doi: 10.1111/j.1365-2125.1993.tb05680.x. Br J Clin Pharmacol. 1993. PMID: 8443032 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources